Bermudez Marcel, Rakers Christin, Wolber Gerhard
Institute of Pharmacy, Freie Universität Berlin, Königin-Luise-Strasse 2+4, 14195 Berlin, Germany phone: +49 30 838 52686; fax: +49 30 838 452686.
Mol Inform. 2015 Aug;34(8):526-30. doi: 10.1002/minf.201500025. Epub 2015 Jul 1.
The high conservation of the orthosteric acetylcholine binding site of muscarinic receptors (MAChR) represents a considerable challenge in terms of designing subtype selective drugs. A promising approach to gain subtype selectivity is to include allosteric or dualsteric targeting that aims to address more specific extracellular binding sites. Despite recent advances in crystallography of G protein coupled receptors (GPCRs), structural information for all 5 MAChR subtypes is not yet available. Here we report structural models of the active and the inactive receptor state of all subtypes derived by homology modelling in combination with MD simulations. The comparison of the allosteric binding site unveils the characteristics for each subtype on a structural level and indicates anchor points for rational design of selective drugs. Additionally, homology models offer the possibility for a rational explanation of dualsteric subtype selectivity, as we show for the M2 over M5 selectivity of the dualsteric ligands Atr-6-naph and Iper-6-phth.
毒蕈碱受体(MAChR)的正构乙酰胆碱结合位点高度保守,这在设计亚型选择性药物方面构成了相当大的挑战。获得亚型选择性的一种有前景的方法是采用变构或双位点靶向,旨在针对更特定的细胞外结合位点。尽管G蛋白偶联受体(GPCRs)晶体学最近取得了进展,但所有5种MAChR亚型的结构信息仍不可用。在此,我们报告了通过同源建模结合分子动力学模拟得出的所有亚型的活性和非活性受体状态的结构模型。变构结合位点的比较在结构水平上揭示了每种亚型的特征,并为选择性药物的合理设计指明了锚定靶点。此外,同源模型为变构亚型选择性提供了合理的解释,正如我们展示的双位点配体Atr-6-naph和Iper-6-phth对M2相对于M5的选择性那样。